Nigeria on Tuesday introduced the human papillomavirus (HPV) vaccine into its routine immunization system, targeting 7.7 million girls aged 9-14 years in preventing at least 70% of cervical cancer cases.
Cervical cancer is the third most common cancer and the second most frequent cause of cancer
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
